Provided by Tiger Fintech (Singapore) Pte. Ltd.

LUYE PHARMA

1.910
+0.1005.52%
Volume:156.65M
Turnover:305.75M
Market Cap:7.18B
PE:14.31
High:2.150
Open:1.800
Low:1.790
Close:1.810
Loading ...

Hong Kong Stocks Reverse Early Losses to End Higher; Pharma Stocks Slide

MT Newswires Live
·
09 Apr

Hong Kong Pharma Stocks Decline as Trump Threatens Tariffs on Imported Drugs

MT Newswires Live
·
09 Apr

Luye Pharma Gets Macao Approval for Antidepressant

MT Newswires Live
·
08 Apr

BRIEF-Luye Pharma Says Antidepressant Ruoxinlin Approved For Marketing In Macao

Reuters
·
07 Apr

Luye Pharma - Class 1 Innovative Antidepressant Ruoxinlin Approved for Marketing in Macao

THOMSON REUTERS
·
07 Apr

Luye Pharma Group Rivastigmine Patch Approved for Alzheimer's Treatment in Japan

MT Newswires Live
·
01 Apr

Luye Pharma - Rivastigmine Twice Weekly Transdermal Patch- Approved for Marketing in Japan

THOMSON REUTERS
·
31 Mar

Institutions profited after Luye Pharma Group Ltd.'s (HKG:2186) market cap rose HK$451m last week but private companies profited the most

Simply Wall St.
·
20 Mar

Investors Appear Satisfied With Luye Pharma Group Ltd.'s (HKG:2186) Prospects

Simply Wall St.
·
11 Feb

Luye Pharma Group Enrolls First Patient in Phase II Trial for New Huntington's Disease Drug

MT Newswires Live
·
16 Jan

Luye Pharma Gets US FDA Approval for Clinical Trials for Schizophrenia Drug

MT Newswires Live
·
15 Jan

BRIEF-Luye Pharma Says Approval Obtained For Group's New Drug Ly03020 For Clinical Trials In U.S.

Reuters
·
14 Jan

Luye Pharma - Approval Obtained for Group's New Drug Ly03020 for Clinical Trials in U.S.

THOMSON REUTERS
·
14 Jan

Here's Why Luye Pharma Group (HKG:2186) Has A Meaningful Debt Burden

Simply Wall St.
·
22 Dec 2024

BRIEF-Luye Pharma Says Executive Chairman Bought Shares Of Co

Reuters
·
18 Dec 2024

Luye Pharma - Executive Chairman Bought 2.0 Mln Ordinary Shares of Co at Average Price of HK$2.2299 per Share on Market

THOMSON REUTERS
·
18 Dec 2024

Zhongtai International Starts Luye Pharma Group at Buy with HK$2.90 Price Target

MT Newswires Live
·
18 Dec 2024

Luye Pharma Group Issues $50 Million Convertible Bonds

MT Newswires
·
16 Dec 2024

Luye Pharma Files for Singapore Listing of $50 Million of Bonds Due in 2025

MT Newswires
·
13 Dec 2024

Luye Pharma Gets Marketing Go-Ahead for Lung Cancer Drug from Chinese Regulator

MT Newswires Live
·
03 Dec 2024